Cibus and Crystal Crop Protection Team Up to Improve India's Mustard CropGlobeNewsWire · Sep 28, 2026
Cibus, Inc. (CBUS) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 13, 2026
Cibus (CBUS) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research · Aug 13, 2026
Cibus Q2 Earnings Call HighlightsMarketBeat · Aug 13, 2026
Cibus Reports Second Quarter Financial Results and Provides Business UpdateGlobeNewsWire · Aug 13, 2026
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference CallGlobeNewsWire · Jul 30, 2026Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.19 | -$0.29 | Miss |
| May 14, 2026 | -$0.35 | -$0.33 | Beat |
| Mar 17, 2026 | -$0.43 | -$0.42 | Beat |
| Nov 13, 2025 | -$0.41 | -$0.44 | Miss |
| Aug 14, 2025 | -$0.69 | -$0.61 | Beat |
| May 8, 2025 | -$0.70 | -$1.34 | Miss |